Sanofi won approval for the use of a drug combination with its Sarclisa infusion to treat certain types of newly diagnosed ...

Analyst Graham Parry of Bank of America Securities maintained a Buy rating on Sanofi (SNYNF – Research Report), retaining the price ...

Sept 16 (Reuters) - Sanofi (SASY.PA), opens new tab and partner AstraZeneca (AZN.L), opens new tab have received approval from the U.S. Food and Drug Administration for a manufacturing line for ...

(RTTNews) - Sanofi (SNYNF, SNY) said it is shipping BEYFORTUS 50mg and 100mg Injection doses in the US to private healthcare providers and to the Centers for Disease Control and Prevention for its ...

Sanofi is following several of its big pharma industry peers into radiopharmaceuticals, striking a deal for a clinical-stage therapy now in discussion for a regulatory submission as a treatment ...

Involves transaction of at least 0.5% of the listed shares of a company. Sanofi Consumer Healthcare India Ltd share price was up by 4.03% from the previous closing price of ₹5,142.70.

Sanofi Consumer Healthcare India Limited has been listed on the BSE and National Stock Exchange (NSE). SCHIL’s demerger from Sanofi India Limited, executed under the Scheme of Arrangement, was ...

Sanofi was ordered to pay €280,000 (£236,539) and Mdm Martin's victory could lead to hundreds of other French challenges. According to French newspaper Le Monde, the court declared Sanofi ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Sanofi is still set on taking its multiple sclerosis (MS) med tolebrutinib to the FDA, executives have told Fierce Biotech, despite the BTK inhibitor falling short in two of three phase 3 trials ...

By Ludwig Burger (Reuters) -Sanofi's most advanced multiple sclerosis drug candidate has missed the main goal of two late-stage trials to treat relapsing forms of the disease, but in a positive ...